SE-ET-TP020d

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameSE-ET-TP020d
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionThrombopoietin receptor agonists
TargetsThrombopoietin receptor
Therapy Area/IndicationsThrombocytopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNascaCell GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNascaCell GmbH
Active IndicationsN/A
Inactive IndicationsThrombocytopenia

Other Information

ATC CodeN/A
Related LinksN/A